![Olivier Samuel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Samuel
No open positions remaining
Net worth: 267 954 $ as of 2026-08-30
Profile
Olivier Samuel currently works at NewCelX Ltd., as Independent Director.
Mr. Samuel also formerly worked at Kadimastem Ltd., as Director from 2020 to 2023 and NLS Pharmaceutics Ltd., as Independent Director.
Mr. Samuel received his Masters Business Admin degree in 2002 from EM Lyon Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.53% | 2026-04-28 | 81,818 ( 1.53% ) | 267 954 $ | 2026-08-30 |
Olivier Samuel active positions
| Companies | Position | Start |
|---|
Former positions of Olivier Samuel
| Companies | Position | End |
|---|---|---|
| NLS PHARPAR | Director/Board Member | - |
Kadimastem Ltd.
 Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Director/Board Member | - |
Training of Olivier Samuel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadimastem Ltd.
Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Health Technology |
NLS Pharmaceutics Ltd.
 NLS Pharmaceutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mental and neurobehavioral disorders | Health Technology |
- Stock Market
- Insiders
- Olivier Samuel
